2000年—2009年上海市嘉定区恶性肿瘤死亡分析

Analysis of Cancer Mortality in Jiading District of Shanghai from 2000 to 2009

目的分析2000年—2009年上海市嘉定区恶性肿瘤的死亡情况,了解10年中因恶性肿瘤导致死亡的变化趋势,为进一步制定肿瘤防治策略提供科学依据。方法收集2000年—2009年上海市死因登记报告系统中,嘉定区恶性肿瘤死亡病例的个案资料,分析其死亡趋势及其与人口老龄化之间的关系。结果 2000年—2009年,嘉定区恶性肿瘤粗死亡率为213.64/105,标化死亡率为108.03/105。其中,男性粗死亡率为266.82/105,标化死亡率为146.12/105;女性粗死亡率为161.05/105,标化死亡率为76.30/105,男性粗死亡率高于女性(χ2=678.90,P=0.000)。2000年—2009年,上海市嘉定区恶性肿瘤粗死亡率呈显著上升趋势[年度变化百分比(APC)=3.861,(P=0.001)],当考虑人口变动和人口老龄化的影响后,恶性肿瘤的标化死亡率比较稳定(APC=-0.444,P=0.450)。老龄系数和恶性肿瘤死亡率之间有明显的线性相关关系。结论 2000年—2009年,嘉定区恶性肿瘤标化死亡率表现出平稳趋势,但由于本区人口老龄程度的不断提高,粗死亡率仍保持显著上升趋势,说明老龄人口比例增加是恶性肿瘤粗死亡率逐年增加的主要因素之一。应针对上海市嘉定区的典型老龄化人口特征,结合老年人各部位肿瘤的发病特点,确定肿瘤防治、危险因素研究的重点和对策。

Objective To describe the death trend from 2000 to 2009 in Jiding District, to provide a scientific basis for the prevention and control of malignant tumor. Methods Data of cancer deaths were analyzed reported from the Death Registration and Reporting system during 2000-2009.The trend and situation were analyzed of cancer mortality in Jiading. Results From 2000 to 2009 the crude mortality was 213.64/105, and the standardized mortality was 108.03/105. The crude and standardized mortality of male were 266.82/105 and 146.12/105 respectively. The crude and standardized mortality of female were 161.05/105 and 76.30/105respectively. The crude mortality of male was higher than that of female(χ2=678.90,P=0.000). The crude mortality trend of malignant tumor was increasing, and annual percentage change(APC) was 3.861(P=0.001). The standardized mortality of male and female was relatively stable(APC=-0.444,P=0.450). Ageing coefficient and cancer mortality showed a significant linear correlation. Conclusion The standardized mortality of cancer was relatively smooth during 2000-2009.Owing to the aging with time,the mortality rate remains significantly increasing. With the arrival of aging society, the malignant tumor has become a major chronic disease endangering human health especially in the elderly population. We should determine our focus and strategy in risk factor research, cancer prevention and treatment, aiming at the typical ageing population characteristics and combining the clinical characteristics of cancer in each body part of the elderly people.